http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1106624-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff15901344342bef4ca57676770131e4 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C321-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0215 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-02 |
| filingDate | 1999-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a933a1e1a0c0ab99e081287ae849e2a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_145f458e85918330a1899bb42be8845e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3365b9df847ec17462d1562f953c59e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42cc56d20cdf4b98c9f4aa846cf333c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd6e2694dd9c854cf88e672f4a4cd1ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da154278578088ef4be9237d8f19ce37 |
| publicationDate | 2003-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1106624-B1 |
| titleOfInvention | 5-membered ring compounds |
| abstract | 5-Membered ring compounds represented by general formula (I), optically active isomers thereof or salts of the same. These compounds have physiological activities including a carcinostatic effect. In said formula the bond shown by the dotted line in the 5-membered ring represents that this 5-membered ring may be either a cyclopentene ring having a double bond or a saturated cyclopentane ring, and when the 5-membered ring is a cyclopentene ring, X is OR1, Y is =O and Z is H, and when it is a cyclopentane ring, X is =O, Y is OR2 and Z is OR3, (wherein R1 is R4 or -(CO)-R5; R2 is H, -R6 or -(CO)-R7; and R3 is H, R8 or (CO)-R9 (wherein R4, R5, R6, R7, R8 and R9 are the same or different and each represents an aliphatic, aromatic or aliphatic aromatic group, and R5, R7 and R9 may be each H), provided that the case where R2=R3=H is excluded); and W represents a residue obtained by eliminating SH from an SH-containing compound. |
| priorityDate | 1998-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 626.